TetraGraph in Rocuronium Infusions

N/AActive Not RecruitingNCT06472284

Joseph D. Tobias50 enrolled

Overview

This is a prospective, non-blinded study to evaluate rocuronium infusion requirements using the TetraGraph Neuromuscular Transmission Monitor during surgical procedures in patients less than 18 yrs. of age.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Surgery

Interventions

TetraGraphDEVICE

etraGraph is a unique, EMG-based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block.

Eligibility

Sex: ALLMin age: 28 DaysMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients less than 18 years of age * American Society of Anesthesiologists classification (ASA) 1-4 * Patients undergoing a surgical procedure with general anesthesia and requiring the continuous administration of rocuroniuim Exclusion Criteria: * Patients less than 28 days old * Patients with history of a progressive or degenerative peripheral neurologic or neuropathic disorder * Patients undergoing a surgical procedure in which neuromuscular blockade is not required * Edematous patients

Locations (1)

Nationwide Children's Hospital

Columbus, Ohio, United States

Outcomes

Primary Outcomes

EMG changes

Changes in the amplitude of the evoked response of the muscles

Time frame: During the surgery (2-8 hrs.)

Maximum dose of rocuronium

The maximum dose of rocuronium administered by a continuous infusion to maintain one twitch of the train of four (TOF)

Time frame: During the surgery (2-8 hrs.)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.